The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $152.80

Today's change0.00 0.00%
Updated January 18 4:00 PM EST. Delayed by at least 15 minutes.
 

United Therapeutics Corp

Nasdaq: UTHR
Last

(U.S.) $152.80

Today's change0.00 0.00%
Updated January 18 4:00 PM EST. Delayed by at least 15 minutes.

United Therapeutics Corp closed at (U.S.)$152.80.

Over the last five days, shares have gained 7.02% and 14.80% over the last 52 weeks. However, this lagged the 20.82%. gain in the S&P 500.

Key company metrics

  • Open(U.S.) $148.61
  • Previous close(U.S.) $152.80
  • High(U.S.) $152.89
  • Low(U.S.) $147.98
  • Bid / Ask(U.S.) $120.51 / (U.S.) $0.00
  • YTD % change+6.53%
  • Volume797,258
  • Average volume (10-day)666,163
  • Average volume (1-month)616,311
  • Average volume (3-month)595,035
  • 52-week range(U.S.) $97.52 to (U.S.) $153.08
  • Beta1.40
  • Trailing P/E10.30×
  • P/E 1 year forward9.53×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $14.84
Updated January 18 4:00 PM EST. Delayed by at least 15 minutes.
S&P TSX0.28%Sector:HealthcareIndustry:Biotechnology

Latest Company News

View more News
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2016Q2/2016Q1/2016Q4/2015
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201609/30/2016Jun 30, 201606/30/2016Mar 31, 201603/31/2016Dec 31, 201512/31/2015
Revenue408413369405
Total other revenue--------
Total revenue408413369405
Gross profit385393368380
Total cost of revenue2420125
Total operating expense1701275250
Selling / general / administrative100725149
Research & development4635076
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total--------
Operating income239285364155
Interest income (expense), net non-operating-1-1-1-1
Gain (loss) on sale of assets0----0
Other--------
Income before tax239286364156
Income after tax162206236105
Income tax, total778012851
Net income162206236105
Total adjustments to net income--------
Net income before extra. items162206236105
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items162206236105
Inc. avail. to common incl. extra. items162206236105
Diluted net income162206236105
Dilution adjustment--------
Diluted weighted average shares46474950
Diluted EPS excluding extraordinary itemsvalue per share3.504.394.842.10
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share3.504.394.842.10